Clinical Trial Update: Pharmacokinetics and Hepatic Safety of EGCG [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics and hepatic safety of EGCG in uterine fibroids; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• EGCG (epigallocatechin gallate)

Snippet

Sponsor: Yale University | Conditions: Uterine Fibroids | Phase 1 | Status: COMPLETED | Results posted: 2023-06-05